SMARTHEALTH DX - Key Persons

Job Titles:

• Chairman
• Chief Medical Officer
• Chief Science Officer
• Founder

Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington began his career as a member of Dr. Jack Copeland's first heart transplant team in Arizona in 1979 and co-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma Study Group headed by Dr. Jim Armitage. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings. Dr. Harrington has developed patents for an automated method for image analysis of residual cancer protein, a patent covering catalytic heavy metal extraction, and a patent pending on biomarker assay for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies - from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval. Throughout his career Dr. Harrington has remained a Clinical Professor of Pathology at the USC Keck School of medicine. Dr. Harrington has authored and published numerous peer-reviewed papers and is renowned lecturer in the area of preventive medicine. Dr. Harrington received his BA in molecular biology, and MD from the University of Colorado at Boulder and is board certified in hematology, anatomic and clinical pathology.

Job Titles:

• Director

Gus J. Blass III is an investment management professional with over 40 years of experience. Mr. Blass has served on the boards of directors for public, non-public as well as non-profit organizations. Mr. Blass qualifies as an "audit committee financial expert" as defined under Securities and Exchange Commission regulations.

Job Titles:

• Chief Commercial Officer
• Director
• Senior Healthcare Executive

Larry Dentice is a highly regarded senior healthcare executive and a 35-year veteran of the diagnostics imaging field with proven expertise in engineering, service, manufacturing, marketing, sales, and business operations for several Fortune 500 companies including Toshiba Medical, Philips Medical, Canon Medical Systems, and GE Healthcare. As Chief Commercial Officer, Mr. Dentice oversees the commercialization and distribution of the entire suite of Smart Health Dx diagnostic and imaging tests.

Job Titles:

• Chief Executive Officer
• Director
• Chief Executive Officer of SMART Health Dx

Matthew Nuñez has served as Chief Executive Officer of SMART Health Dx since 2019. Mr. Nuñez, an entrepreneur, has built businesses in diagnostic biomarker discovery, bioinformatics, advanced analytics, and precision medicine.

Job Titles:

• Chief Financial Officer
• Director
• President
• Strategic - Minded Chief Financial Officer

Mitch Levine is a strategic-minded Chief Financial Officer, corporate finance innovator, and investment industry leader who has orchestrated mission-critical financial strategies to enhance corporate value and strengthen operating performance for both public and private companies in the life sciences industry. From 2017 to 2022, Mr. Levine was the Chief Financial Officer of Oncocyte (OCX: NasdaqGM) a molecular diagnostic company, where he oversaw corporate growth from eight employees to more than 120; conducted 10 capital raises bringing the company to fully-funded status; built the shareholder base from one institutional investor to more than 50; negotiated and integrated three acquisitions; and secured the largest licensing deal in company history with one of the largest and fastest-growing diagnostic laboratories in China. From 2000 to 2017, Mr. Levine was Founder and Managing Member of Enable Capital Management, LLC, whose underlying investment vehicle, Enable Growth Partners, LP, was one of the largest funds providing growth capital to small and mid-sized public and private companies. Prior to Enable Capital Management, Mr. Levine was a Founding Member of the Shemano Group, a San Francisco-based investment bank focused on the capital needs of technology and life science companies where Mr. Levine was widely recognized for originating and developing one of the largest alternative financing markets in the US, generating more than $100 billion of financings annually.

Job Titles:

• Director

15+ years of experience leading and transforming organizations with disruptive diagnostic technologies to revenue stage companies with market leading tests. Six capital raises including three underwritten deals. Launched multiple diagnostics globally, as kits and CLIA services, driving test inclusion as standard-of-care. Expertise in oncology and transplant monitoring markets. Track record of securing favorable Medicare and Commercial payor coverage and payment. Drive execution excellence across R&D, Medical Affairs, Operations and Commercial to deliver high quality products and service that deliver customer satisfaction and repeat business.

Job Titles:

• President Imaging Technologies

Paul Dentice brings tremendous experience to his new role as part of the SMART Health Dx executive team. Mr. Dentice has over 20 years of experience in diagnostic imaging, sales, technical, and leadership roles. He has had success within his roles with several healthcare industry leaders including Siemens and Philips Healthcare. Throughout Mr. Dentice's career he has maintained an impressive track record for developing key relationships with market leaders and academics, exceeding quotas, and growing market share with his team.

Job Titles:

• Director
• Vice Chairman, Healthcare

Mr. Fatheazam is Vice Chairman, Healthcare for global investment banking advisory firm Lincoln International, where he manages the firm's strategic efforts and provides senior-level advisory services on mergers and acquisitions (M&A), capital raising, technology licensing, and other services for healthcare companies worldwide. His focus areas include global diagnostics and pharma outsourcing. Prior to joining Lincoln, Fatheazam led the healthcare practice of GCA Savvian, where he successfully advised most of the firm's Japanese merger transactions in the U.S. Previously, he was a senior partner at Vector Securities International, expanding the firm's healthcare services practice. He began his career with Kidder, Peabody & Co.

Job Titles:

• Chief Operating Officer & President Laboratory Services

Susie Lu brings years of experience to her role as Chief Operating Officer and as President of Laboratory Services. She has a proven record of running large scale, highly complex laboratory operations by providing visionary and operational direction for the development and implementation of laboratory outreach programs in institutions. Some of Ms. Lu's successes include, Columbia HCA Hospitals where she was an Executive Director; UCSF Health/Mount Zion Hospital, Stanford Health System/Lucile Packard Children's Hospital, UCLA Health System/Santa Monica Hospital, where she served as Vice President of Operations; and Zhe Jiang University Medical Center in China, where she is the Chief Consultant (since 2014).

Job Titles:

• Founder of Hangzhou Huili Medical Technology Development Co. LTD

Yonghong Wu, PhD is a Founder of Hangzhou Huili Medical Technology Development Co. LTD, one of the largest distributors of medical instruments and supplies in China, working with Roche, Johnson & Johnson, Abbott Diagnostics & Thermo Fisher. She has over 30 years of experience in Chinese healthcare industry. As one of the top three in vitro diagnostic reagent service providers in Zhejiang Province, she has been awarded the Outstanding Economic Contribution Award for eight consecutive years.